For weight loss, tirzepatide generally produced larger average weight loss in clinical trials, roughly 15% to 21% across doses, versus around 15% for semaglutide
Novo Nordisk and Eli Lilly may very well be producing adequate stock of semaglutide and tirzepatide to meet national demand, while patients still struggle to access the drugs due to logistical challenges
Proper injection technique, purchasing from reputable sources, and consulting with healthcare providers can help reduce the risk of side effects
While the score correlated with who was likely to lose weight on semaglutide, nongenetic factors also played a big role, Cirulli says
[PMID: 3295441] PubMed record related to this compound for laboratory literature review
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and allows precise dose adjustment based on your response, without price increases as you optimize your regimen